Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.500
-0.100 (-6.25%)
At close: May 14, 2025, 4:00 PM
1.600
+0.100 (6.67%)
After-hours: May 14, 2025, 7:08 PM EDT
Metagenomi Stock Forecast
MGX's stock price has decreased by -77.1% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Metagenomi stock ranges from a low of $7.00 to a high of $17. The average analyst price target of $13.75 forecasts a 816.67% increase in the stock price over the next year.
Price Target: $13.75 (+816.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Metagenomi stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $16 | Buy | Maintains | $20 → $16 | +966.67% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $7 | Strong Buy | Maintains | $14 → $7 | +366.67% | Apr 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +1,233.33% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $14 | Strong Buy | Maintains | $7 → $14 | +833.33% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +366.67% | Nov 21, 2024 |
Financial Forecast
Revenue This Year
32.23M
from 52.30M
Decreased by -38.37%
Revenue Next Year
34.47M
from 32.23M
Increased by 6.95%
EPS This Year
-2.43
from -2.36
EPS Next Year
-2.29
from -2.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 48.9M | 71.4M | 17.6M |
| Avg | 32.2M | 34.5M | 13.5M |
| Low | 9.8M | 9.8M | 9.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.4% | 121.5% | -48.9% |
| Avg | -38.4% | 7.0% | -60.8% |
| Low | -81.3% | -69.6% | -71.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.54 | -0.57 | -2.99 |
| Avg | -2.43 | -2.29 | -3.31 |
| Low | -3.52 | -3.53 | -3.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.